After Hottods Update note yesterday I contacted POH and was surprisingly put through to Harry Rosen.We discussed how the invoicing fraud was discovered and in particular was a stocktake discrepancy identified by Anna Legg the start of the unwinding of the fraud concealment.In typical lawyer speak from my point of view I did not get a clear yes or no.
Further discussions with HR indicated:
^Esragate is still having an effect on company status
^POH keep a close eye on any possible competitor progress.POH is still the only company to deliver OxyC orOxyM transdermally or topically.This item came up as I was asking about product development delays and POH losing out to possible competitor progress.
^Any opioid pill that works can be abused[by taking more pills]This may seem obvious but it is worth noting.
^Paul Gavin was more relevant to the development of TPM in the clinic than Esra Ogru.
Harry Rosen was a pleasure to talk to and answered or commented on matters discussed in as direct a manner as possible..I had never previously talked to Harry Rosen.
Kens
- Forums
- ASX - By Stock
- Update
After Hottods Update note yesterday I contacted POH and was...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $3.722K | 1.413M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 94288418 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 76032683 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 94288418 | 0.002 |
19 | 77595010 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 76032683 | 22 |
0.004 | 17087707 | 16 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |